BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2009
View Archived Issues
First pediatric patient treated with Aptocine in neurofibromatosis study
Read More
Hana reaches enrollment target for phase II Marqibo trial in ALL
Read More
Zilver PTX Drug-Eluting Peripheral Stent receives approval in Europe
Read More
Antisoma and Bryan Oncor enter agreement for anticancer drug P-2045
Read More
Neurobiological Technologies terminates agreement with Merz and CMCC
Read More
Dynavax meets with EMEA for Heplisav HBV vaccine development strategy
Read More
FDA accepts to file Theratechnologies' tesamorelin NDA
Read More
Kuros reports data with KUR-212 in burn victims requiring mesh grafting
Read More
Labopharm submits response to FDA complete response letter for trazodone
Read More
Vedrop receives marketing authorization in the European Union
Read More
Tolerx amends phase III DEFEND protocol
Read More
Anadys reports viral load data for ANA-773 in hepatitis C patients
Read More
Avanir presents phase III study results for Zenvia
Read More
Anti-bovine thrombin 4A IgG cross-reacts with human thrombin and Recothrom
Read More
CB1/CB2 receptor antagonist THCV displays anticonvulsant activity in rat model of epilepsy
Read More
Novel antithrombotic agent S-35972 displays promising preclinical activity
Read More
Preclinical and early clinical data indicate that EP-42675 is a potent anticoagulant
Read More
O-3223 shows potency in preclinical models of inflammatory and neuropathic pain
Read More
PF-2341066 displays clinical activity in EML4-ALK translocation-positive NSCLC
Read More
Wyeth identifies liver X receptor modulators for the treatment of lipoprotein disorders
Read More
MEK kinase inhibitors for cancer treatment presented by Genentech
Read More
LG Life Sciences claims glucokinase activators for the treatment of diabetes
Read More
Merck & Co. describe c-Met kinase inhibitors for cancer treatment
Read More
Novel alpha2-adrenoceptor ligands in early development at Allergan
Read More
Novel tyrosine hydroxylase inducers discovered by French investigators
Read More